Latest Breaking News On - New chemical entity - Page 14 : comparemela.com

FSD Pharma Completes Dosing of First Cohort in Phase I Clinical Trial of Lucid-MS, a New Drug Candidate for the Treatment of Multiple Sclerosis: Safety Review Committee Recommends Commencing Dosing of Second Cohort

FSD Pharma Inc. , a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and. | May 10, 2023

Lakshmi kotraBiosciences incCompany annual report on formCompany phaseExchange commissionLucid psychss incPharma incLucid psycheceuticalsMultiple sclerosisNew chemical entityPsychss incCanadian securities administratorsAnnual reportFsd pharma inc stock exchangePress releaseNflammatory huge ca35954b2066

CorMedix (CRMD) Announces Notice of Allowance for U S Patent Application Covering Lead Product DefenCath

CorMedix (CRMD) Announces Notice of Allowance for U S Patent Application Covering Lead Product DefenCath
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesDan ferrymanaging directorlifesciJoe todiscoTrademark officeCormedix incDrug administrationSecurities exchangeWall streetUnited states patentNew drug applicationCatheter related bloodstream infectionsNew chemical entityQualified infectious disease productNapproved drug productsTherapeutic equivalence evaluationsOrange book

CorMedix (CRMD) Announces Regulatory, Manufacturing and Reimbursement Updates

CorMedix (CRMD) Announces Regulatory, Manufacturing and Reimbursement Updates
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Joe todiscoDan ferrymanaging directorlifesciCenters for medicare medicaid servicesCormedix incSecurities exchangeWall streetNew drug applicationNew technology add on paymentMedicaid servicesInpatient prospective payment systemFast trackQualified infectious disease productNew chemical entityComplete response letterPrivate securities litigation reform actSecurities act

CorMedix Inc Announces Regulatory, Manufacturing and Reimbursement Updates

CorMedix Inc Announces Regulatory, Manufacturing and Reimbursement Updates
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Joe todiscoDan ferrymanaging directorlifesciSecurities exchangeCenters for medicare medicaid servicesCormedix incNew drug applicationNew technology add on paymentMedicaid servicesInpatient prospective payment systemFast trackQualified infectious disease productNew chemical entityComplete response letterPrivate securities litigation reform actSecurities actSecurities exchange act

FSD Pharma Achieves Milestone in Completion of Dosing of Sentinel Subjects in First-in-Human Clinical Trial of Lucid-MS (Lucid-21-302) for Multiple Sclerosis

FSD Pharma Inc. , a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory and. | April 17, 2023

Lakshmi kotraPharma incMs international foundation atlasCompany phaseBiosciences incCompany annual report on formMarket researchLucid psychss incExchange commissionMs societyMultiple sclerosisLucid psycheceuticalsNew chemical entityAllied market researchPsychss incCanadian securities administrators